• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Hygieia appoints diabetes veteran Doug Lawrence as CEO

August 23, 2022 By Sean Whooley

Hygieia CEO Doug Lawrence
[Image from Hygieia]
Hygieia — a developer of digital therapeutics for insulin therapy — announced today that it appointed Doug Lawrence as its CEO.

Lawrence will take the corner office at Livonia, Michigan-based Hygieia with responsibilities for leading operations, development, and global growth of the company and its d-Nav insulin management program. The FDA-cleared d-Nav system autonomously adjusts insulin dose recommendations to correspond to a patient’s changing insulin needs.

He joins with three decades of medtech leadership, including significant experience bringing products to market, restructuring and guiding companies through mergers and acquisitions, building global sales teams, raising venture capital, and overseeing operations, according to a news release.

Among Lawrence’s previous roles include CEO at CeQur, which makes insulin patch pumps for the type 2 diabetes market. Before that, he led the diabetes business at BD, which has since spun off to become Embecta.

“Doug has the perfect combination of experience and skill to shepherd Hygieia’s expansion in the United States and around the world,” Eran Bashan, Hygieia co-founder and board chair, said in the release. “Now, with Doug serving as CEO, we will work together to build the nation’s leading network of diabetes clinics. The world of healthcare delivery is rapidly changing, and Doug’s leadership will allow us to accelerate our go-to-market plan. We are looking forward to partnering with others to simplify insulin therapy and improve outcomes.”

Hygieia’s recent growth initiatives include the launch of the d-Nav clinical partnership program in May, international expansion with a licensing agreement in Israel and a partnership renewal with the National Health Service in Northern Ireland and the American Medical Association’s approval of two new Category III codes for autonomous insulin dose titration, which can be used with d-Nav.

“Diabetes is a global epidemic imposing tremendous costs on patients and health systems,” Lawrence said. “Late stage, insulin-dependent diabetes can be incredibly challenging for patients and their medical partners to manage effectively. I’m thrilled to join this talented, passionate team whose proven, FDA-cleared d-Nav Technology is poised to transform the safety and efficacy of insulin therapy and, in many cases, lower the overall cost of diabetes management.”

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Personnel, Technology Tagged With: hygieia, Personnel, Personnel Moves

IN CASE YOU MISSED IT

  • Abbott could pave new roads in diabetes management with dual sensor on the horizon
  • Tandem Diabetes Care pairs t:slim X2 pump with Abbott FreeStyle Libre 3 Plus in U.S.
  • Ypsomed, CamDiab to integrate Abbott dual glucose-ketone sensor into automated insulin delivery system
  • PharmaSens, SiBionics collab on all-in-one insulin patch pump
  • Beta Bionics to pair iLet automated insulin delivery system with Abbott’s dual glucose-ketone sensor

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS